Validity and Reliability of the Korean Version of the Florida Patient Acceptance Survey.

Abstract

Aim: To validate the Korean version of the Florida Patient Acceptance Survey (K-FPAS) and assess its reliability in evaluating the acceptance of implantable cardioverter defibrillators (ICDs) among Korean patients.

Design: A methodological research study was conducted to develop and validate the K-FPAS as a valuable tool for assessing ICD acceptance and its related factors in the Korean patient population.

Methods: A total of 243 participants, aged 18 years and older, who had received ICDs within the past year and were regularly monitored by cardiac specialists, were included in the study. The K-FPAS was meticulously translated and underwent expert validation, exploratory factor analysis, and confirmatory factor analysis to establish its construct validity. Content validity was confirmed by seven experts, and concurrent validity was examined using the Short Form-36 Health Survey. The reliability of the K-FPAS was assessed for internal consistency.

Results: The K-FPAS demonstrated robust content and construct validity, consisting of 15 items organised into four subdomains: "Return to Life," "Device-Related Distress," "Positive Appraisal," and "Body Image Concerns."

Conclusion: The K-FPAS is a valid and reliable instrument for evaluating ICD acceptance among Korean patients. It provides a robust methodological framework for exploring the multidimensional facets of ICD acceptance, particularly highlighting the significance of psychological and emotional well-being. This tool demonstrates considerable potential for advancing nursing research and guiding evidence-based interventions to enhance ICD acceptance and improve the overall quality of life for ICD recipients.

Patient or public contribution: Patients contributed to this study by providing responses on the study questionnaires, and five hospitals supported the data collection process by providing suitable facilities for interviews and questionnaires. This research aims to benefit patients and improve their well-being through better ICD acceptance assessment and support.